Synergism of small molecules targeting VDAC with sorafenib, regorafenib or lenvatinib on hepatocarcinoma cell proliferation and survival by Ventura, C., Junco, M., Santiago Valtierra, F.X., Gooz, M., Zhiwei, Y., Townsend, D.M., Woster, P.M., Maldonado, E.N.

Get full text